American Journal of Cardiology
Volume 104, Issue 2 , Pages 182-189 , 15 July 2009

Predictors of Six-Month Major Adverse Cardiac Events in 30-Day Survivors After Acute Myocardial Infarction (from the Korea Acute Myocardial Infarction Registry)

  • Jang Hoon Lee, MD

      Affiliations

    • Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea
  • ,
  • Hun Sik Park, MD

      Affiliations

    • Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea
  • ,
  • Shung Chull Chae, MD

      Affiliations

    • Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea
    • Corresponding Author InformationCorresponding author: Tel: 82-53-420-5527; fax: 82-53-426-2959
  • ,
  • Yongkeun Cho, MD

      Affiliations

    • Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea
  • ,
  • Dong Heon Yang, MD

      Affiliations

    • Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea
  • ,
  • Myung Ho Jeong, MD

      Affiliations

    • Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea
  • ,
  • Young Jo Kim, MD

      Affiliations

    • Department of Internal Medicine, Yeungnam University Hospital, Daegu, Republic of Korea
  • ,
  • Kee-Sik Kim, MD

      Affiliations

    • Department of Internal Medicine, Daegu Catholic University Hospital, Daegu, Republic of Korea
  • ,
  • Seung Ho Hur, MD

      Affiliations

    • Department of Internal Medicine, Keimyung University, Dongsan Medical Center, Daegu, Republic of Korea
  • ,
  • In Whan Seong, MD

      Affiliations

    • Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea
  • ,
  • Taek Jong Hong, MD

      Affiliations

    • Department of Internal Medicine, Pusan National University Hospital, Pusan, Republic of Korea
  • ,
  • Myeong Chan Cho, MD

      Affiliations

    • Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea
  • ,
  • Chong Jin Kim, MD

      Affiliations

    • Department of Internal Medicine, Kyung Hee University East-West Neo Medical Center, Seoul, Republic of Korea
  • ,
  • Jae Eun Jun, MD

      Affiliations

    • Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea
  • ,
  • Wee Hyun Park, MD

      Affiliations

    • Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea
  • ,
  • Korea Acute Myocardial Infarction Registry Investigators

      Affiliations

    • Investigators of the Korea Acute Myocardial Infarction Registry (KAMIR) are listed in the Appendix.

Received 20 December 2008 ,Revised 3 March 2009 ,Accepted 3 March 2009.

References 

  1. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291:2727–2733
  2. Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, et al. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction (Analyses of patient subgroups in the Thrombolysis In Myocardial Infarction (TIMI) trial, phase II). Circulation. 1992;85:1254–1264
  3. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis (Results of the GISSI-2 data base). Circulation. 1993;88:416–429
  4. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction (Results from an international trial of 41,021 patients). Circulation. 1995;91:1659–1668
  5. Lee SR, Jeong MH, Ahn YK, Chae SC, Hur SH, Kim YJ, et al. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. Circ J. 2008;72:392–398
  6. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart. 2004;90:99–106
  7. Califf RM, Pieper KS, Lee KL, Van de Werf F, Simes RJ, Armstrong PW, et al. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation. 2000;101:2231–2238
  8. Mehta RH, O'Neill WW, Harjai KJ, Cox DA, Brodie BR, Boura J, et al. Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions. Am J Cardiol. 2006;97:817–822
  9. Buettner HJ, Mueller C, Gick M, Ferenc M, Allgeier J, Comberg T, et al. The impact of obesity on mortality in UA/non–ST-segment elevation myocardial infarction. Eur Heart J. 2007;28:1694–1701
  10. Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS, et al. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol. 2006;110:153–159
  11. Nikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, et al. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J. 2006;151:168–175
  12. Mehta L, Devlin W, McCullough PA, O'Neill WW, Skelding KA, Stone GW, et al. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2007;99:906–910
  13. Michaels AD, Goldschlager N. Risk stratification after acute myocardial infarction in the reperfusion era. Prog Cardiovasc Dis. 2000;42:273–309
  14. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moyé LA, Dagenais GR, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction (The protective effects of captopril). Circulation. 1994;89:68–75
  15. Benhorin J, Moss AJ, Oakes D. Prognostic significance of nonfatal myocardial reinfarction (Multicenter Diltiazem Postinfarction Trial Research Group). J Am Coll Cardiol. 1990;15:253–258
  16. Volpi A, de Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, et al. Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis (Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) data base). J Am Coll Cardiol. 1994;24:608–615
  17. Sanz G, Castañer A, Betriu A, Magriña J, Roig E, Coll S, et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med. 1982;306:1065–1070
  18. Shihara M, Tsutsui H, Tsuchihashi M, Tada H, Kono S, Takeshita A Japanese Coronary Invention Study (JCIS) Group. In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2002;90:932–936
  19. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?. Circulation. 1988;78:1157–1166
  20. Behar S, Goldbourt U, Reicher-Reiss H, Kaplinsky E. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation (Principal Investigators of the SPRINT study). Am J Cardiol. 1990;66:1208–1211
  21. Furman MI, Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol. 2001;37:1571–1580
  22. Cobb LA, Baum RS, Alvarez H, Schaffer WA. Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up. Circulation. 1975;52:III223–III235
  23. Eldar M, Sievner Z, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality (The SPRINT Study Group). Ann Intern Med. 1992;117:31–36
  24. Volpi A, Cavalli A, Santoro L, Negri E. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction—results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. Am J Cardiol. 1998;82:265–271
  25. Tofler GH, Stone PH, Muller JE, Rutherford JD, Willich SN, Gustafson NF, et al. Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS study) (Multicenter Investigation of the Limitation of Infarct Size). Am J Cardiol. 1987;60:755–761
  26. Al-Khatib SM, Granger CB, Huang Y, Lee KL, Califf RM, Simoons ML, et al. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation. 2002;106:309–312
  27. Al-Khatib SM, Stebbins AL, Califf RM, Lee KL, Granger CB, White HD, et al. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. Am Heart J. 2003;145:515–521
  28. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014–1021
  29. Lindahl B, Lindbäck J, Jernberg T, Johnston N, Stridsberg M, Venge P, et al. Serial analyses of N-terminal pro–B-type natriuretic peptide in patients with non–ST-segment elevation acute coronary syndromes: a Fragmin and Fast Revascularisation During Instability in Coronary Artery Disease (FRISC)-II substudy. J Am Coll Cardiol. 2005;45:533–541

 Drs. Jang Hoon Lee and Hun Sik Park contributed equally to this article.

PII: S0002-9149(09)00729-2

doi: 10.1016/j.amjcard.2009.03.010

American Journal of Cardiology
Volume 104, Issue 2 , Pages 182-189 , 15 July 2009